digipharm®
Home •  Site Map  •  Research  •  Reports  •  International Experts  •  Music Preparations  •  Fundamentals  •  News  •  Questions  •  Shop
digipharm®
peter huebner • micro music laboratories
M E D I C A L   R E S O N A N C E   T H E R A P Y   M U S I C®
R E D U C T I O N   O F   P S Y C H O – P H Y S I O L O G I C A L   M A N I F E S T A T I O N S   O F   S T R E S S

SCIENTIFIC RESEARCH

Research Fields Summary

Headaches

Migraine

Sleep Disorders

Pains

Neurodermatitis

Psoriasis

Medication Consumption

Dermatology

Dispersion of Stress

Faster Recovery

Mental Distress / Fear

Dizziness

Cardiovascular System

Hormone / Immune System

The Mental State

Operations

Radiation Sickness

ENT

Multiple Sclerosis

Gerontology

Diabetes

Cerebral & Nervous System

Mental & Sensory Abilities

Pediatrics

Pregnancy & Birth

Gynecology

Epilepsy

Concentration / Memory

Courage to Face Life

Creativity

Harmony

Mother & Child

Neurophysiological &
Sensory Disorders

Relaxation

Vital Energy

 

 






Scientific Studies and Clinical Observations – Summary
Health of the Nervous System
Headaches
  • Reduction in the frequency of headaches in patients suffering from severe radiation sickness: prior to the treatment the frequency of headaches stood at an average of 95%, after 10 days’ application this had fallen to an average of 12%.

  • Reducing the frequency of headache attacks in pregnant women from 73% to 20%. In the control group there was an increase from 60% to 70%.

  • Dispersion of headaches following surgery – after treatment 62% of the reports documented complete eradication of the headaches.

  • Reduction of headaches in 81% of a group of female diabetes patients.

  • Significant reduction in headaches in 80% of a group of children with diabetes, compared to no appreciable reduction in the control group.

  • Reduction of headaches in older people and people of middle-age with atherosclerotic encephalopathy: of the 25 patients examined 21 had headaches.
    After the treatment 15 patients were free of headaches, 5 experienced a significant improvement and one patient experienced no improvement.

  • A significant reduction of medication for headaches in patients with severe migraines – at its peak by 70%.
 


  Headache / Migraine   For this indication please use the program:

HEADACHE / MIGRAINE
 
  If you want to look at the studies in detail, please visit:
SCIENTIFIC STUDIES & CLINICAL OBSERVATIONS – COMPLETE STUDIES
With kind permission of AAR EDITION INTERNATIONAL
© 1998-  DIGIPHARM >